drugset / Trial / NCT01529190

Pregabalin on Interleukin-6 Levels in Living Donor Kidney

NCT01529190

Phase 2 Completed 40 enrolled Federal University of São Paulo
RandomizedParallel-groupTriple-blindTreatment

Summary

Pregabalin, a ligand for alfa2delta subunits of voltage-gated calcium channels, has been shown to be an effective adjuvant therapy for acute postoperative pain, by inhibiting central sensitization. The IL-6, is detectable 60 minutes after surgical incision, persisting for until 10 days, with maximal plasmatic level in 4 and 6 hours. The objective of this study is evaluating the analgesic effect of pregabalin and its repercussion on serum levels of IL6.

Timeline

Start
2011-03
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pregabalin Small molecule 300 mg

Indications

No indication recorded.